GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea · Delayed Price · Currency is KRW

4,825.00

0.00 (0.00%)

At close: Sep 11, 2026

GeneBioTech Co. ,Ltd Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	89,315	90,789	82,959	79,477	82,759	62,814
Revenue Growth	0.97%	9.44%	4.38%	-3.96%	31.75%	6.25%
Gross Profit	15,287	14,256	13,370	13,652	10,349	7,439
Operating Income	4,609	3,996	3,844	3,973	1,557	-453.15
Net Income	3,672	3,789	2,865	2,591	1,523	-484.4
Earnings Per Share	427.00	440.02	333.00	300.95	176.91	-56.26
EPS Growth	2.14%	32.14%	10.65%	70.12%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	27,436	24,897	23,404	22,016	16,090	17,790
Total Debt	17,448	14,957	15,885	12,502	13,029	10,302
Net Cash (Debt)	9,988	9,940	7,519	9,514	3,061	7,488
Net Cash Growth	110.98%	32.20%	-20.97%	210.80%	-59.12%	-65.62%
Net Cash Per Share	1161.41	1154.38	873.87	1104.91	355.50	869.68

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	5,360	7,614	-463.87	7,369	-3,679	-2,713
Capital Expenditures	-834.9	-3,758	-1,100	-530.02	-1,155	-3,102
Free Cash Flow	4,525	3,856	-1,564	6,838	-4,834	-5,816
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	17.12%	15.70%	16.12%	17.18%	12.50%	11.84%
Operating Margin	5.16%	4.40%	4.63%	5.00%	1.88%	-0.72%
Pretax Margin	4.82%	4.86%	4.22%	4.25%	2.19%	-1.33%
Profit Margin	4.11%	4.17%	3.45%	3.26%	1.84%	-0.77%
FCF Margin	5.07%	4.25%	-1.89%	8.60%	-5.84%	-9.26%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	50.000	-	-	-	-	-
Dividend Per Share Growth	0%	-	-	-	-	-
Dividend Yield	1.07%	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	11.30	9.11	9.89	14.49	22.55	-
P/FCF Ratio	9.18	8.95	-	5.49	-	-
PS Ratio	0.47	0.38	0.34	0.47	0.42	0.72